PDB Short entry for 13GS HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-NOV-97 13GS TITLE GLUTATHIONE S-TRANSFERASE COMPLEXED WITH SULFASALAZINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GST; COMPND 5 EC: 2.5.1.18; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX (TRANSFERASE-SULFASALAZINE), TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.J.OAKLEY,M.LO BELLO,M.W.PARKER REVDAT 7 02-AUG-23 13GS 1 REMARK REVDAT 6 21-DEC-11 13GS 1 HET SEQRES REVDAT 5 13-JUL-11 13GS 1 VERSN REVDAT 4 24-FEB-09 13GS 1 VERSN REVDAT 3 25-JAN-05 13GS 1 AUTHOR JRNL REVDAT 2 02-FEB-99 13GS 1 AUTHOR REVDAT 1 13-JAN-99 13GS 0 JRNL AUTH A.J.OAKLEY,M.LO BELLO,M.NUCCETELLI,A.P.MAZZETTI,M.W.PARKER JRNL TITL THE LIGANDIN (NON-SUBSTRATE) BINDING SITE OF HUMAN PI CLASS JRNL TITL 2 GLUTATHIONE TRANSFERASE IS LOCATED IN THE ELECTROPHILE JRNL TITL 3 BINDING SITE (H-SITE). JRNL REF J.MOL.BIOL. V. 291 913 1999 JRNL REFN ISSN 0022-2836 JRNL PMID 10452896 JRNL DOI 10.1006/JMBI.1999.3029 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.2 REMARK 3 NUMBER OF REFLECTIONS : 33654 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1670 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 67.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2444 REMARK 3 BIN R VALUE (WORKING SET) : 0.3020 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 141 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3277 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 132 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 15.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.30 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.850 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.060 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.100 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.640 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.300 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : SUL.PAR REMARK 3 PARAMETER FILE 3 : MES.PAR REMARK 3 PARAMETER FILE 4 : WATER.PRO REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : MES.TOP REMARK 3 TOPOLOGY FILE 3 : SO4.TOP REMARK 3 TOPOLOGY FILE 4 : SUL.TOP REMARK 3 TOPOLOGY FILE 5 : GGLU.PRO REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 13GS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170092. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-MAR-96 REMARK 200 TEMPERATURE (KELVIN) : 288 REMARK 200 PH : 5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33656 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 62.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.24100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.140 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.851 REMARK 200 STARTING MODEL: PDB ENTRY 1GSS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 39.72750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.55350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 39.72750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 45.55350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 0 REMARK 465 PRO B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A 190 CE LYS A 190 NZ -0.167 REMARK 500 LYS B 190 CE LYS B 190 NZ -0.164 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 64 113.25 83.48 REMARK 500 THR A 141 -114.32 -119.82 REMARK 500 GLN B 64 113.50 83.01 REMARK 500 THR B 141 -113.44 -119.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH A 210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH B 210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAS A 211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAS B 211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B 212 DBREF 13GS A 1 209 UNP P09211 GTP_HUMAN 1 209 DBREF 13GS B 1 209 UNP P09211 GTP_HUMAN 1 209 SEQRES 1 A 210 MET PRO PRO TYR THR VAL VAL TYR PHE PRO VAL ARG GLY SEQRES 2 A 210 ARG CYS ALA ALA LEU ARG MET LEU LEU ALA ASP GLN GLY SEQRES 3 A 210 GLN SER TRP LYS GLU GLU VAL VAL THR VAL GLU THR TRP SEQRES 4 A 210 GLN GLU GLY SER LEU LYS ALA SER CYS LEU TYR GLY GLN SEQRES 5 A 210 LEU PRO LYS PHE GLN ASP GLY ASP LEU THR LEU TYR GLN SEQRES 6 A 210 SER ASN THR ILE LEU ARG HIS LEU GLY ARG THR LEU GLY SEQRES 7 A 210 LEU TYR GLY LYS ASP GLN GLN GLU ALA ALA LEU VAL ASP SEQRES 8 A 210 MET VAL ASN ASP GLY VAL GLU ASP LEU ARG CYS LYS TYR SEQRES 9 A 210 ILE SER LEU ILE TYR THR ASN TYR GLU ALA GLY LYS ASP SEQRES 10 A 210 ASP TYR VAL LYS ALA LEU PRO GLY GLN LEU LYS PRO PHE SEQRES 11 A 210 GLU THR LEU LEU SER GLN ASN GLN GLY GLY LYS THR PHE SEQRES 12 A 210 ILE VAL GLY ASP GLN ILE SER PHE ALA ASP TYR ASN LEU SEQRES 13 A 210 LEU ASP LEU LEU LEU ILE HIS GLU VAL LEU ALA PRO GLY SEQRES 14 A 210 CYS LEU ASP ALA PHE PRO LEU LEU SER ALA TYR VAL GLY SEQRES 15 A 210 ARG LEU SER ALA ARG PRO LYS LEU LYS ALA PHE LEU ALA SEQRES 16 A 210 SER PRO GLU TYR VAL ASN LEU PRO ILE ASN GLY ASN GLY SEQRES 17 A 210 LYS GLN SEQRES 1 B 210 MET PRO PRO TYR THR VAL VAL TYR PHE PRO VAL ARG GLY SEQRES 2 B 210 ARG CYS ALA ALA LEU ARG MET LEU LEU ALA ASP GLN GLY SEQRES 3 B 210 GLN SER TRP LYS GLU GLU VAL VAL THR VAL GLU THR TRP SEQRES 4 B 210 GLN GLU GLY SER LEU LYS ALA SER CYS LEU TYR GLY GLN SEQRES 5 B 210 LEU PRO LYS PHE GLN ASP GLY ASP LEU THR LEU TYR GLN SEQRES 6 B 210 SER ASN THR ILE LEU ARG HIS LEU GLY ARG THR LEU GLY SEQRES 7 B 210 LEU TYR GLY LYS ASP GLN GLN GLU ALA ALA LEU VAL ASP SEQRES 8 B 210 MET VAL ASN ASP GLY VAL GLU ASP LEU ARG CYS LYS TYR SEQRES 9 B 210 ILE SER LEU ILE TYR THR ASN TYR GLU ALA GLY LYS ASP SEQRES 10 B 210 ASP TYR VAL LYS ALA LEU PRO GLY GLN LEU LYS PRO PHE SEQRES 11 B 210 GLU THR LEU LEU SER GLN ASN GLN GLY GLY LYS THR PHE SEQRES 12 B 210 ILE VAL GLY ASP GLN ILE SER PHE ALA ASP TYR ASN LEU SEQRES 13 B 210 LEU ASP LEU LEU LEU ILE HIS GLU VAL LEU ALA PRO GLY SEQRES 14 B 210 CYS LEU ASP ALA PHE PRO LEU LEU SER ALA TYR VAL GLY SEQRES 15 B 210 ARG LEU SER ALA ARG PRO LYS LEU LYS ALA PHE LEU ALA SEQRES 16 B 210 SER PRO GLU TYR VAL ASN LEU PRO ILE ASN GLY ASN GLY SEQRES 17 B 210 LYS GLN HET GSH A 210 20 HET SAS A 211 28 HET MES A 212 12 HET MES A 213 12 HET GSH B 210 20 HET SAS B 211 28 HET MES B 212 12 HETNAM GSH GLUTATHIONE HETNAM SAS 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL) HETNAM 2 SAS AZO)BENZOIC ACID HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN SAS SULFASALAZINE FORMUL 3 GSH 2(C10 H17 N3 O6 S) FORMUL 4 SAS 2(C18 H14 N4 O5 S) FORMUL 5 MES 3(C6 H13 N O4 S) FORMUL 10 HOH *182(H2 O) HELIX 1 1 ARG A 11 ARG A 13 5 3 HELIX 2 2 CYS A 14 GLN A 24 1 11 HELIX 3 3 THR A 34 GLU A 40 1 7 HELIX 4 4 GLY A 41 CYS A 47 1 7 HELIX 5 5 GLN A 64 GLY A 77 1 14 HELIX 6 6 ASP A 82 ASN A 110 1 29 HELIX 7 7 ASN A 110 GLN A 135 1 26 HELIX 8 8 ASN A 136 LYS A 140 5 5 HELIX 9 9 SER A 149 ALA A 166 1 18 HELIX 10 10 PHE A 173 ALA A 185 1 13 HELIX 11 11 ARG A 186 ALA A 194 1 9 HELIX 12 12 SER A 195 ASN A 200 1 6 HELIX 13 13 ARG B 11 ARG B 13 5 3 HELIX 14 14 CYS B 14 GLN B 24 1 11 HELIX 15 15 THR B 34 GLU B 40 1 7 HELIX 16 16 GLY B 41 CYS B 47 1 7 HELIX 17 17 GLN B 64 GLY B 77 1 14 HELIX 18 18 ASP B 82 ASN B 110 1 29 HELIX 19 19 ASN B 110 GLN B 135 1 26 HELIX 20 20 ASN B 136 LYS B 140 5 5 HELIX 21 21 SER B 149 ALA B 166 1 18 HELIX 22 22 PHE B 173 ALA B 185 1 13 HELIX 23 23 ARG B 186 ALA B 194 1 9 HELIX 24 24 SER B 195 ASN B 200 1 6 SHEET 1 A 4 LYS A 29 VAL A 32 0 SHEET 2 A 4 TYR A 3 TYR A 7 1 N VAL A 5 O GLU A 31 SHEET 3 A 4 LYS A 54 ASP A 57 -1 O LYS A 54 N VAL A 6 SHEET 4 A 4 LEU A 60 TYR A 63 -1 O LEU A 62 N PHE A 55 SHEET 1 B 4 TRP B 28 VAL B 32 0 SHEET 2 B 4 TYR B 3 TYR B 7 1 N VAL B 5 O GLU B 31 SHEET 3 B 4 LYS B 54 ASP B 57 -1 O LYS B 54 N VAL B 6 SHEET 4 B 4 LEU B 60 TYR B 63 -1 O LEU B 62 N PHE B 55 CISPEP 1 LEU A 52 PRO A 53 0 -0.30 CISPEP 2 LEU B 52 PRO B 53 0 0.14 SITE 1 AC1 12 TYR A 7 PHE A 8 ARG A 13 TRP A 38 SITE 2 AC1 12 LYS A 44 GLN A 51 LEU A 52 GLN A 64 SITE 3 AC1 12 SER A 65 SAS A 211 HOH A 310 ASP B 98 SITE 1 AC2 11 ASP A 98 TYR B 7 ARG B 13 TRP B 38 SITE 2 AC2 11 LYS B 44 GLN B 51 LEU B 52 PRO B 53 SITE 3 AC2 11 GLN B 64 SER B 65 SAS B 211 SITE 1 AC3 10 PHE A 8 PRO A 9 VAL A 10 ARG A 13 SITE 2 AC3 10 VAL A 35 ILE A 104 TYR A 108 PRO A 202 SITE 3 AC3 10 GLY A 205 GSH A 210 SITE 1 AC4 4 ALA A 22 TRP A 28 GLU A 30 GLU A 197 SITE 1 AC5 7 ARG A 74 TYR A 79 ASP A 82 GLN A 83 SITE 2 AC5 7 ALA A 86 ARG B 74 TYR B 79 SITE 1 AC6 11 PHE B 8 PRO B 9 VAL B 10 ARG B 13 SITE 2 AC6 11 VAL B 35 ILE B 104 TYR B 108 PRO B 202 SITE 3 AC6 11 GLY B 205 GSH B 210 HOH B 248 SITE 1 AC7 4 ALA B 22 TRP B 28 GLU B 30 GLU B 197 CRYST1 79.455 91.107 69.559 90.00 98.44 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012586 0.000000 0.001867 0.00000 SCALE2 0.000000 0.010976 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014534 0.00000 MTRIX1 1 0.943782 0.096311 0.316226 -5.53149 1 MTRIX2 1 0.096847 -0.995200 0.014061 22.12543 1 MTRIX3 1 0.316062 0.017356 -0.948580 27.64538 1